1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. UROGEN PHARMA LTD
UroGen Pharma Ltd XNAS: URGN

UroGen Pharma Ltd Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing...

Read More
21.25 -2.22 (-9.46%)
29.17% Fall from 52W High
852.1K
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
7.2 / 100
Momentum Score
Technically Neutral
52.3 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
35
1Yr Price target upside is 66%
8 analysts

13

S

10

W

6

O

0

T

SWOT Analysis

UroGen Pharma Ltd Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..